This session will explore the pathophysiology of respiratory depression due to opioid administration, identifying high-risk patients, and the respiratory therapist's role in patient monitoring and prevention of opioid-induced respiratory depression.
Original webcast date: January 29, 2014
Approved for 1.0 CRCE Hour
This webcast is sponsored in part by an unrestricted educational grant from Covidien.
**Please note that all programs require the participant to view the entire program prior to taking the final quiz and obtaining a course certificate.**
- Discuss the pathophysiology of respiratory depression due to opioid administration
- Identify high risk patients for respiratory depression due to opioid administration
- Identify the respiratory therapist's role in patient monitoring and prevention of opioid-induced respiratory depression